Antigen-Specific Immune Responses and Clinical Outcome After Vaccination With Glioma-Associated Antigen Peptides and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Children With Newly Diagnosed Malignant Brainstem and Nonbrainstem Gliomas [Pediatric Oncology]

Conclusion GAA peptide vaccination in children with gliomas is generally well tolerated and has preliminary evidence of immunologic and clinical responses. Careful monitoring and management of pseudoprogression is essential.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Tags: Brain Tumors, CNS Tumors Pediatric Oncology Source Type: research